DECREASED PREVALENCE OF IMMEDIATE HYPERSENSITIVITY (ATOPY) IN A CANCER POPULATION.ALLEGRA J; LIPTON A; HARVEY H et al.1976; CANCER RES.; U.S.A.; DA. 1976; VOL. 36; NO 9 PART. 1; PP. 3225-3226; BIBL. 12 REF.Article

Pharmacokinetics and cyclooxygenase inhibition of itazigrel in normal volunteers after single oral dosesPOE-HIRR HSYU; KOETS, M. D; LUDERER, J. R et al.Journal of pharmaceutical sciences. 1994, Vol 83, Num 12, pp 1747-1750, issn 0022-3549Article

Rapid extraction of arachidonic acid metabolites utilizing octadecyl reversed-phase columnsLUDERER, J. R; RILEY, D. L; DEMERS, L. M et al.Journal of chromatography. 1983, Vol 273, Num 2, pp 402-409, issn 0021-9673Article

Effects of nadolol and propranolol on plasma lidocaine clearanceSCHNECK, D. W; LUDERER, J. R; DAVIS, D et al.Clinical pharmacology and therapeutics. 1984, Vol 36, Num 5, pp 584-587, issn 0009-9236Article

Age and ceftriaxone kineticsLUDERER, J. R; PATEL, I. H; DURKIN, J et al.Clinical pharmacology and therapeutics. 1984, Vol 35, Num 1, pp 19-25, issn 0009-9236Article

Continuous intravenous dosing with ciprostene using a portable pump in ambulatory patientsWOLF, D. L; METZLER, C. M; FROESCHKE, M. O et al.Journal of clinical pharmacology. 1993, Vol 33, Num 2, pp 150-153, issn 0091-2700Article

Arachidonic acid metabolism in the platelets of hemophiliacs with prolonged bleeding timesLUDERER, J. R; LOCKE, L; ZEKOSKI, M et al.Thrombosis research. 1983, Vol 31, Num 4, pp 539-548, issn 0049-3848Article

The haemodynamic effects and pharmacokinetics of intravenous nicorandil in healthy volunteersWOLF, D. L; FERRY, J; HEARRON, A. E et al.European journal of clinical pharmacology. 1993, Vol 44, Num 1, pp 27-33, issn 0031-6970Article

Acute effects of increasing doses of nicorandil on renal function in manWOLF, D. L; JUNGBLUTH, G. L; METZLER, C. M et al.International journal of clinical pharmacology and therapeutics. 1994, Vol 32, Num 5, pp 246-253, issn 0946-1965Article

The pharmacokinetics and haemodynamic effects of continuous nicorandil infusion in healthy volunteersWOLF, D. L; HEARRON, A. E; METZLER, C. M et al.European journal of clinical pharmacology. 1993, Vol 45, Num 5, pp 437-443, issn 0031-6970Article

The effect of itazigrel and aspirin on the mucosa of the esophagus, stomach, and duodenum of normal subjectsDEMKE, D. M; LUDERER, J. R; WAKEFIELD, L. K et al.Journal of clinical pharmacology. 1987, Vol 27, Num 11, pp 916-920, issn 0091-2700Article

Familial essential thrombocythemiaEYSTER, M. E; SALETAN, S. L; RABELLINO, E. M et al.The American journal of medicine. 1986, Vol 80, Num 3, pp 497-502, issn 0002-9343Article

Safety and risk/benefit analysis of ibutilide for acute conversion of atrial fibrillation/flutterKOWEY, P. R; VANDERLUGT, J. T; LUDERER, J. R et al.The American journal of cardiology. 1996, Vol 78, Num 8A, pp 46-52, issn 0002-9149Conference Paper

Dose-related haemodynamic effects and pharmacokinetics of oral nicorandil in patients evaluated for chest painARNOLD, J. M. O; KOWEY, P. R; WOLF, D. L et al.International journal of cardiology. 1994, Vol 44, Num 3, pp 203-215, issn 0167-5273Article

Dazoxiben, a thromboxane synthetase inhibitor, in Raynauds phenomenonLUDERER, J. R; NICHOLAS, G. G; NEUMYER, M. M et al.Clinical pharmacology and therapeutics. 1984, Vol 36, Num 1, pp 105-115, issn 0009-9236Article